Socio-economic inequalities in first-time use of antidepressants: a population-based study

Eur J Clin Pharmacol. 2004 Mar;60(1):51-5. doi: 10.1007/s00228-003-0723-y. Epub 2004 Feb 17.

Abstract

Objective: To analyse whether first-time use of antidepressants (incidence) and selection of TCAs (tricyclic antidepressants) versus new-generation drugs are associated with socio-economic status and psychiatric history.

Method: We conducted a population-based cohort study using registry data covering Funen County, Denmark. A total of 305,953 adult residents without antidepressant prescriptions 5 years prior to the study period (1998) were included.

Results: The 1-year incidence rate of antidepressant prescription (1.7%) increased with age. It was higher in people who were female, less educated, unemployed, those receiving old-age or disability pension, low-income groups, and singles. The proportion prescribed new-generation antidepressants (82%) showed no difference according to socio-economic variables (education, annual income and socio-economic group), but was higher among the young and single. Admission to psychiatric hospital within 4 years prior to the study period was associated with high-incidence rate of antidepressant prescription and overall a preference for the new-generation antidepressants.

Conclusion: Socio-economic status did not seem to influence the selection of TCAs versus new-generation antidepressants. Compatible with the general epidemiology of depression, low socio-economic status was associated with a high number of first-time users of antidepressants in the population, and the incidence rate increased with age.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antidepressive Agents / therapeutic use*
  • Cohort Studies
  • Denmark
  • Drug Prescriptions / statistics & numerical data
  • Female
  • Humans
  • Male
  • Mental Disorders
  • Middle Aged
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Pharmacoepidemiology / methods
  • Pharmacoepidemiology / statistics & numerical data*
  • Socioeconomic Factors*
  • Time Factors

Substances

  • Antidepressive Agents
  • Monoamine Oxidase Inhibitors